Stockreport

Delcath Systems Q4 Earnings Call Highlights [Yahoo! Finance]

Delcath Systems, Inc.  (DCTH) 
US:NASDAQ Investor Relations: delcath.com/investors
PDF 20% HEPZATO KIT volume growth and 10% CHEMOSAT growth, with an expected average selling price of ~ per HEPZATO kit reflecting ~10% 340B-related discount. 2025 performa [Read more]